Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma × Norethindrone Acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leiomyoma 5 Menorrhagia 4 Pregnancy Complications 1 Observational Study 1 Lymphoma 1 Endometriosis 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 388 Rituximab 340 Etoposide 195 Vincristine 182 Filgrastim 176 Doxorubicin 172 Prednisone 146 Radiotherapy 138 Cytarabine 138 fludarabine phosphate 124 Methotrexate 117 Melphalan 113 Peripheral Blood Stem Cell Transplantation 108 fludarabine 104 Busulfan 86 Dexamethasone 77 Carmustine 65 Granulocyte Colony-Stimulating Factor 62 Tacrolimus 60 Whole-Body Irradiation 56 Mycophenolic Acid 56 Gemcitabine 56 Bendamustine Hydrochloride 56 Antilymphocyte Serum 55 Lenalidomide 53 Ifosfamide 51 Cyclosporine 51 Bortezomib 49 Methylprednisolone 43 Leucovorin 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01160315 2015-10-30

Erasme-POF

Erasme University Hospital

Phase 2/3 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡